Objective: To examine the possible crosstalk and the roles of angiotensin (Ang) II type 1 (AT1) and type 2 (AT2) receptors in the control of apoptosis in fetal vascular smooth muscle cells (VSMCs). Methods: Fetal VSMCs were prepared from rat fetal aorta at embryonic day 20. Expression of Ang II receptors was measured by a radioligand binding assay. Apoptotic changes were assessed by caspase 3 activity and chromatin dye staining. Regulation of extracellular signal-regulated kinase (ERK) activity via Ang II receptors was analysed by determinating phosphorylated ERK with Western blot. Ang II receptor-mediated activation of tyrosine phosphatase SHP-1 was assessed by protein tyrosine phosphatase assay. Results: The expression of AT1 and AT2 receptors was approximately 70%: 30% per cell. Serum depletion induced apoptosis in fetal VSMCs and selective AT1 receptor stimulation attenuated the apoptotic changes, whereas selective AT2 receptor activation enhanced apoptosis. Ang II increased ERK phosphorylation, which was inhibited by addition of the AT1 receptor-specific antagonist CV11974, but enhanced by addition of the AT2 receptor-specific antagonist PD123319, suggesting that activation of AT2 receptor attenuated the AT1 receptor-mediated ERK phosphorylation. Moreover, we demonstrated that AT2 receptor stimulation activated SHP-1 in fetal VSMCs, whereas AT1 receptor stimulation did not. Transient transfection of a dominant-negative SHP-1 mutant into rat fetal VSMCs resulted in a significant decrease of the AT2 receptor-mediated inhibition of ERK phosphorylation and attenuated the proapoptotic effect of AT2 receptor. Conclusion: These results indicate that a crosstalk between AT1 and AT2 receptors regulates the survival of fetal VSMCs and substantiate SHP-1 as a key molecule in AT2 receptor signaling.
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Introduction
transmembrane, G protein-coupled receptor family, recent evidence reveals that the functions of AT1 and AT2 Angiotensin (Ang) II is classically considered as a receptors are mutually antagonistic. The AT2 receptor is vasoconstricting, progrowth molecule acting via stimulaabundantly and widely expressed in fetal tissues, but tion of the G protein-coupled seven membrane-spanning present only at low levels in adult tissues and re-expressed Ang II type 1 (AT1) receptor. In addition to the 'classical' in certain pathological conditions such as ovarian atresia, AT1 receptor, it is now conceivable that Ang II activates wound injury, myocardial infarction, and vascular injury another receptor subtype (type 2 or AT2 receptor). Al- [1] . The highly abundant expression of this receptor during though both AT1 and AT2 receptors belong to the sevenembryonic and neonatal growth and its quick disappearance after birth has led us to the suggestion that this receptor may be involved in growth, development and / or differentiation. In many organs, tissue remodeling and Sprague-Dawley rat fetuses (embryonic day 20) and degeneration involve an active process, termed apoptosis cultured in Dulbecco's modified Eagle's medium (DMEM) (programmed cell death), which is a ubiquitous, evolution-(Life Technologies Inc., Rockville, Maryland, USA) supally conserved, physiological mechanism of cell death that plemented with 10% fetal bovine serum (FBS) as previregulates mass and architecture in many tissues. The ously described [19] . In addition to the morphological genetic program for apoptosis may be activated at a observation, characterization of VSMC was examined by defined time during embryogenesis or in the maturation of indirect immunofluoresence using a monoclonal antibody adult cells, by a wide range of physiological stimuli. These specific for a-smooth muscle actin (clone 1A4; Sigma results provide us with the possibility that AT2 may induce Chemical Co.) [20] . Our culture of fetal VSMCs exhibited apoptosis. Actually proapoptotic effects of AT2 receptor the 'hill-and-valley' appearance which is characteristic of have been demonstrated in PC12W cells [2] [3] [4] [5] , R3T3 adult VSMC. The cells were uniformly positive for amouse fibroblasts [2, 4] , rat ovarian granulosa cells [6] , smooth muscle actin by immunofluorescence. These results human umbilical venous endothelial cells [7] and AT2
indicate that the cells are characteristic of VSMC although receptor-transfected adult rat VSMCs [8] .
the possible contamination of fibroblasts and endothelial The growth inhibitory effects of the AT2 receptor have cells cannot be avoided. All the experiments were perbeen shown to associate with the activation of a series of formed using the cells at the second or third passage. AT1 phosphatases including the protein tyrosine phosphatase and AT2 receptor binding was measured as previously SHP-1 [9, 10] or the mitogen-activated protein kinase described [19] . phosphatase-1 (MKP-1) [2, 4] , and the serine / thronine phosphatase 2A (PP2A) [11] , which results in the inactiva-2.2. Plasmid constructs and transfection tion of AT1 receptor-and / or growth factor-activated extracellular signal-regulated kinase (ERK). SHP-1 [for-
The SHP-1 (C453 / S) mutant and SHP-2 (C463 / S) merly termed PTP1C, SH-PTP-1, SHP, and HCP], a two mutant cDNA were inserted into the pcDNA3 vector [21] . Src homology 2 (SH2) domain-containing cytosolic
Transient transfection was performed with 0.5 mg of tyrosine phosphatase, has been implicated in the negative plasmid DNA per well of a six-well plate and Lipofecregulation of a broad spectrum of growth-promoting tAMINE PLUS (GIBCO-BRL) according to the manufacreceptors, including receptor tyrosine kinases such as c-Kit turer's instructions (DNA:LipofectAMINE:PLUS ratio, [12, 13] , TrK A [14] , and epidermal growth factor (EGF) 1:10:10 ml). After transient transfection, the transfected [15] receptors; cytokine receptors such as interleukin-3 cells were fed with complete growth medium for 48 h to (IL-3) [12] , interferon-a / b [16] and erythropoietin [17] allow protein expression. Transfected cells were identified receptors; and B cell FcgRIIB [18] receptor. Given the by b-galactosidase staining. The transfection efficiency breadth of its interaction with multiple growth factor was 2565%, a similar level as previously reported [22] . receptors, we hypothesize that SHP-1 is involved in AT2
Overexpression of SHP-1 (C453 / S) mutant and SHP-2 receptor intracellular pathway which negatively crosstalks (C463 / S) mutant was confirmed by immunoblot with an with AT1 receptor signaling. Moreover, we have recently anti-SHP-1 or an anti-SHP-2 antibody (Santa Cruz Bioobserved that SHP-1 is one of the most proximal effector technology, Inc.). in AT2 receptor-mediated ERK inhibition and apoptosis in PC12 cells [10] .
2.3. Determination of cell death Accordingly, we used fetal VSMC, which endogenously express both AT1 and AT2 receptors, and examined the Rat fetal VSMCs were grown in 10% FBS DMEM to a possibilities that AT2 receptor stimulation exerts proapopsubconfluent state in 10-cm dishes and incubated for an totic effects by antagonizing the function of AT1 receptor additional 48 h in serum-free DMEM. Nuclear chromatin and that SHP-1 is pivotal in the proapototic effect of AT2 morphology analysis and caspase-3 activity assay were receptor stimulation.
used as quantitative indices of apoptosis. Nuclear chromatin morphology was analyzed by staining with Hoechst 33342 (Molecular Probes, Inc., Eugene, Oregon, USA) and 2. Methods viewed under fluorescence microscopy, as previously described [2] . The caspase-3 activity assay was performed The investigation conforms with the Guide for the Care using an adaptation of a previously described protocol and Use of Laboratory Animals published by the US [23] . Results were normalized to basal activity in viable National Institutes of Health (NIH Publication No. 85-23, cells maintained in serum-containing medium. revised 1996).
Determination of ERK activity 2.1. Cell culture
Subconfluent VSMCs were incubated in serum-free Fetal VSMCs were prepared from the thoracic aortae of DMEM for 24 h and were treated with vehicle or Ang II (0.3 mmol / l) with or without PD123319 (10 mmol / l) or Serum starvation induced a significant increase in caspase-CV11974 (10 mmol / l) for 15 min. The activation of ERK 3 activity, reaching a maximum at 12 h and declining to was assessed as previously described [19] . Briefly, the basal level within 48 h (Fig. 1A) . However, the addition of cells were washed quickly with HEPES-buffered saline, Ang II (0.3 mmol / l) significantly inhibited caspase-3 frozen in liquid nitrogen, scraped and lysed. The lysate activation measured at 12 h after serum depletion (Fig. was centrifuged for 20 min at 60003g at 48C. Protein 1B). Stimulation with Ang II (0.3 mmol / l) in the presence concentration was measured in the cleared supernatant by of AT2 receptor-specific antagonist PD123319 (10 mmol / Bio-Rad protein assay. The supernatant (20 mg) was l) further inhibited caspase-3 activity compared with subjected to SDS-polyacrylamide gel electrophoresis stimulation with Ang II alone (Fig. 1B) . On the contrary, (PAGE) and electrotransferred onto Hybond-ECL nitroaddition of the AT1 receptor-specific antagonist CV11974 cellulose membrane. Phosphorylated or total ERK was (10 mmol / l), Ang II stimulation further increased the detected with a phospho-ERK antibody or a total ERK serum starvation-induced caspase-3 activation (Fig. 1B) . antibody (New England Biolabs Inc., Beverly, MassachuNeither CV11974 nor PD123319 alone influenced the setts, USA), respectively, visualized by enzyme-linked caspase 3 activity (Fig. 1B) To explore the molecular mechanism involved in the cross-talk of AT1 and AT2 receptors in regulating cell 2.5. Measurement of SHP-1 tyrosine phosphatase death in rat fetal VSMCs, we examined ERK activation in activity response to the stimulation of AT1 or / and AT2 receptors.
As shown in Fig. 2A and B, immunoblot using an antiSubconfluent VSMCs were incubated in serum-free phospho-ERK antibody demonstrates that Ang II (0.3 DMEM for 24 h and were treated with vehicle or Ang II mmol / l) stimulation significantly increased ERK phos-(0.3 mmol / l) with or without PD123319 (10 mmol / l) or phorylation. CV11974 (10 mmol / l) strongly attenuated the CV11974 (10 mmol / l) for 3 min. SHP-1 tyrosine phosphaAng II-induced ERK phosphorylation. In contrast, tase activity was measured as previously described [9, 10] . PD123319 (10 mmol / l) significantly enhanced the Ang II-induced ERK phosphorylation. ERK phosphorylation 2.6. Data analysis was not affected by treatment with CV11974 (10 mmol / l) and PD123319 (10 mmol / l) alone. All values are expressed as mean6S.E.M. The data were evaluated by analysis of variance followed by a Newman-3.3. Activation of AT2 receptor increases SHP-1 activity Keuls' test for multiple comparisons. The difference was in fetal VSMCs considered to be significant if P,0.05. We first examined the protein level of SHP-1 in rat fetal VSMCs and found that SHP-1 is expressed in fetal VSMC 3. Results (Fig. 3A) . Next we examined the SHP-1 activity and observed that Ang II (0.3 mmol / l) stimulation for 3 min 3.1. Cross-talk of AT1 and AT2 receptors regulate cell significantly increased SHP-1 activity and this Ang IIdeath in fetal VSMCs mediated SHP-1 activation was blocked with PD123319 (10 mmol / l) but not by CV11974 (10 mmol / l) (Fig. 3B) . To examine the role of endogenous AT2 receptor in Ang II regulated apoptosis, we employed VSMC prepared from rat fetal aorta. VSMCs were cultured from the aorta of fetal 3.4. Role of SHP-1 in AT2 receptor-induced apoptosis rat at embryonic day 20, and shown to express both AT1 in fetal VSMCs To investigate whether SHP-1 plays a role in the mean6S.E.). Upon serum starvation for 24 h, chromatin proapoptotic effect of AT2 receptor, we transfected rat dye staining showed that VSMCs underwent morphologifetal VSMCs with a dominant negative (dn) SHP-1 mutant cal changes of typical apoptosis, such as fragmented nuclei in which the active site cysteine 453 was mutated to serine with condensed chromatin (data not shown). We character-(C453 / S) [21] . Overexpression of dnSHP-1 mutant was ized the time course of caspase-3 activation after serum confirmed by immunoblot showing 6-fold increase in SHPdeprivation in our system and we examined the effects of 1 immunoreactivity compared with the control vector Ang II (Fig. 1A,B) , since caspase-3 plays a central role in pcDNA3 transfected cells (Fig. 3A) . Basal SHP-1 activity serum or trophic factor deprivation-induced apoptosis.
was low in VSMCs transfected with dnSHP-1 mutant and we could not observe further significant increase in SHP-1 dnSHP-2 transfection did not modify the effect of Ang II activity in response to Ang II (Fig. 3C) . We then examined on ERK activation (Fig. 4) . Moreover, we observed that the functional significance of SHP-1 activation on AT2 transfection of dnSHP-1 or dnSHP-2 did not influence the receptor-mediated ERK inhibition and apoptosis. Since the protein levels of total ERK (Fig. 4A) . Next we examined SHP-2 phosphatase [formerly termed SHPTP-2, SHPTP-3, the effect of Ang II treatment on apoptotic changes in Syp, PTP2C, and PTP1D], in contrast to SHP-1, frequently dnSHP-1 or dnSHP-2 transfected rat fetal VSMCs (Fig. 5 ). functions as a positive effector of growth-stimulatory Upon serum starvation for 12 h, a near 4-fold increase in signaling pathway, we also examined the possible incaspase-3 activity was observed in each transfectant ( . In control vector pcDNA3 transfected VSMCs, Ang II and cell death by Ang II in rat fetal VSMCs. After (0.3 mmol / l) stimulation led to inhibition of the caspase-3 identification of endogenous expression of SHP-2 in rat activation, which was enhanced by addition of PD123319 fetal VSMCs by immunoblot, we transfected rat fetal (10 mmol / l), and selective activation of AT2 receptor by VSMCs with a dnSHP-2 mutant in which the active site Ang II in presence of CV11974 (10 mmol / l) further cysteine 463 was mutated to serine (C463 / S). Overexpresincreased the caspase-3 activation induced by serumsion of dnSHP-2 mutant was confirmed by immunoblot starvation (Fig. 5) , as that observed in non-transfected showing 3-fold increase in SHP-2 immunoreactivity comVSMCs (Fig. 1B) . However, the enhancement of Ang II pared with the control vector pcDNA3 transfected cells stimulation-induced inhibition of the caspase-3 activation (Fig. 3A) . We first examined the ERK activation in cells by PD123319 or the aggravation of serum starvationoverexpressing dnSHP-1 or dnSHP-2 (Fig. 4) . In dnSHP-1 induced caspase-3 activation by Ang II in presence of transfected VSMCs, increase in ERK activity by Ang II CV11974 were blocked by overexpression of dnSHP-1 in was further significantly enhanced compared to that in VSMCs (Fig. 5) . Transfection of dnSHP-2 did not modupcDNA3 transfected VSMCs and ERK activation by Ang late the effects of Ang II on caspase-3 activation caused by II was not influenced with PD123319 (Fig. 4) . In contrast, serum depletion in VSMCs (Fig. 5) . 4. Discussion the AT2 receptor in rat embryonic blood vessels is 'turned on' at late gestation (embryonic days [16] [17] [18] [19] [20] [21] and early Increasing evidence reveals that AT2 receptor acts as an neonatal period, but decreases rapidly to very low levels in antagonist against the classical AT1 receptor, i.e. the AT2 the adult vessel [24, 25] . The spatial and temporal patterns receptor exerts antigrowth, antihypertrophic, and proapopof rat vascular AT2 receptor expression, together with its totic effects and promotes differentiation [1] . Expression of growth modulatory action, have led us to hypothesize that this receptor plays an important role in vascular developwe found that activation of AT1 increases ERK phosment and remodeling in late gestation. Indeed, pharmacophorylation and activation of AT2 receptor shows an logical blockade of the AT2 receptor using the specific inhibitory effect on the AT1 receptor-mediated ERK antagonist PD123319 during rat embryonic days [16] [17] [18] [19] [20] [21] phosphorylation. Such opposite modulation of ERK by results in increased aortic DNA synthesis [24] . Our AT1 and AT2 receptors was also observed in rat cultured previous results using AT2 receptor null mice suggest that neurons, which contained both AT1 and AT2 receptors AT2 receptor promotes vascular differentiation and contri- [29] . Our results suggest that the facilitating effect of AT2 butes to vasculogenesis [26] . Moreover, we observed that receptor stimulation on serum deprivation-induced cell VSMCs prepared from the aorta of fetal or newborn AT2 death in fetal VSMCs is at least partly due to the inhibitory receptor null mice showed enhanced proliferative activity effect of AT2 receptor activation on ERK phosphorylation. [19] . Here we demonstrate that Ang II regulates apoptosis SHP-1 is a soluble tyrosine phosphatase that participates in fetal VSMCs, i.e. stimulation of AT1 receptor inhibits in the negative regulation of receptor tyrosine kinase apoptosis, whereas activation of AT2 receptor potentiates pathway [12] [13] [14] [15] . Our previous results have shown that it. These results provide further support to the hypothesis stimulation of AT2 receptor rapidly activates SHP-1 in that Ang II-regulated programmed cell death is involved in N1E-115 and AT2 receptor-transfected Chinese hamster vascular development or vasculogenesis.
ovary (CHO) cells [9] , and that SHP-1 is a proximal To explore the molecular mechanism of Ang II-regeffector of the AT2 receptor, implicated in the apoptotic ulated apoptosis in fetal VSMCs, we focused on ERK effect of AT2 receptor in PC12 cells [10] . Therefore we activation since the ERK cascade is crucial in proliferation, speculated that SHP-1 may be a key molecule in AT2 differentiation, and hypertrophy or apoptosis of VSMC receptor signaling in rat fetal VSMCs. We observed that [27] , and is likely involved in AT2 receptor-mediated stimulation of AT2 receptor also rapidly activates SHP-1 antigrowth and proapoptotic actions on VSMC [8, 24, 28] .
in rat fetal VSMCs, where AT1 activation does not. To In cultured VSMCs prepared from embryonic day 20 rat, establish a functional link between AT2 receptor-mediated activation of SHP-1 and inactivation of ERK, we used a vation of insulin receptor kinase in CHO cells, leading to catalytically inactive, dominant negative (dn) mutant SHPinhibition of ERK phosphorylation and cell proliferation 1 and demonstrated that preventing SHP-1 activation [33] . Therefore, it is likely that ERKs may not be direct abrogates AT2 receptor stimulation-induced ERK inhibicellular targets for AT2 receptor-activated SHP-1, but tion in rat fetal VSMCs. Moreover, the ERK inhibition is rather that AT2 receptor-activated SHP-1 affects upstream due to activation / phosphorylation, not to translation of intermediates of AT1 receptor-induced ERK pathway such ERK, since total protein level of ERK was not changed by as EGF receptor. overexpression of dnSHP-1 in rat fetal VSMCs.
The result of inhibition of AT2 receptor-mediated It has already been demonstrated that for a number of apoptosis by overexpression of dnSHP-1 suggests that the membrane receptors such as EGF receptor, SHP-1 termiproapoptotic effect of AT2 receptor is associated with the nated these receptors' signal by direct interaction with the inactivation of ERK via a signaling pathway involving the receptors [12, 15, 17, 18] . Tyrosine kinase activation by the activation of SHP-1 in rat fetal VSMCs. In addition, sst2 AT1 receptor is at least partly attributed to transactivation somatostatin receptor-mediated activation of SHP-1 has of a tyrosine kinase receptor such as the epidermal growth been shown to act as an initial transducter of the antipfactor (EGF) receptor or the platelet derived growth factor roliferating signaling mediated by this receptor [21] . It is (PDGF) receptor [30] [31] [32] . In VSMC, Ang II stimulation interesting that SHP-1 has been reported to be required for has been shown to activate the EGF receptor by tyrosine the delivery of the Fas apoptosis signal in lymphoid cell phosphorylation [31] . Very recent evidence showed that [34] . These observation suggest that SHP-1 is a transducer activation of AT2 receptor results in functional transinactiof the antimitogenic and / or proapoptotic signals mediated which contributes to the pathogenesis and remodeling of cardiovascular diseases. In summary, these results provide us with direct evidences that crosstalk between AT1 and AT2 receptor controls the fate of fetal VSMCs. It is also possible that this antagonistic interaction may contribute to the fetal vascular development or vasculogenesis. We also demonstrated that SHP-1 is a pivotal effector in the signal transduction pathway of AT2 receptor in fetal VSMCs.
